Alcon (ALC) reported a quarter with higher profit, a slightly light top line and a narrower outlook. Investors focused on the last two. The Geneva-based eye-care company released its third-quarter 2026 results after Tuesday's U.S. close, and its shares were lower in both Zurich and New York on Wednesday.

A Small Sales Miss, a Narrower Year

Want to apply this to your own portfolio?Open OptionsPilot →

Alcon said third-quarter net sales rose 5% to $2,717 million, from $2,589 million a year earlier. Core diluted earnings per share rose 15% to $0.91, and IFRS diluted EPS was $0.54. Seeking Alpha reported the core EPS figure as $0.02 ahead of estimates, with revenue about $40 million short.

The outlook table carried most of the weight:

| 2026 outlook (constant currency) | August | November | Net sales growth+5% to +7%about +6% Core operating margin change+90 to +190 bps+100 to +150 bps | Core diluted EPS growth | +12% to +15% | +12% to +14% |

Alcon also now assumes its served markets grow about 3% this year. Reuters reported that was down from a prior range of 3% to 4%, and that implantable sales, which include intraocular lenses used in cataract surgery, fell 2% in the quarter.

The Tariff Refund Inside the Margin

The release said Alcon received a refund of about $60 million from the U.S. government in the third quarter, and that roughly two-thirds of that benefit is being reinvested in the business. Reuters cited JPMorgan analysts who calculated that operating profit would have missed expectations by about 9% without a $58 million tariff refund, rather than the slight beat it posted. A one-time item like that can make a headline beat look stronger than the run rate behind it, which is often how the market reads it.

Zurich Down About 6%, New York Down About 4%

Reuters reported Alcon shares down around 6% in Swiss trading on Wednesday morning, on track for their worst day in six months. In New York, Yahoo Finance data showed ALC near $71.05 at about 11:19 a.m. ET, down about 4.1% from Tuesday's $74.06 close, after trading between $70.34 and $72.34 on volume of about 2.1 million shares.

The Event Premium Left Even as the Stock Dropped

A falling stock doesn't always lift implied volatility. Once a report is out, the uncertainty it carried is resolved, and that premium tends to leave the options. Cboe delayed quotes from early in Wednesday's session, with ALC near $71.99, showed:

  • 30-day implied volatility: about 31.3%, down about 10.3 points from the prior close, a drop of roughly a quarter.
  • November 20 $72.50 straddle: about $3.18 at the midpoint, or roughly 4.4% of the share price, for nine days to expiration.
  • December 18 $72.50 straddle: about $5.13 at the midpoint, or roughly 7.1%.

    • Puts led the tape at about 766 contracts against 156 calls. The busiest line was the November 20 $70 put, at about 502 contracts, against open interest of about 1,456. Quotes were wide in places (that put showed $0.20 bid and $1.25 ask), so midpoints are rough estimates, not likely fills.

    What a Post-Earnings Medtech Chain Usually Offers

    With the event behind it, ALC's remaining catalysts are slower-moving: competition in implantables, the cataract market's growth rate and Alcon's formal 2027 guidance, which management said would come in February. In educational terms:

  • Long puts after the drop pay for a move that has partly happened already. Lower implied volatility makes them cheaper than they were Tuesday, but they still lose value daily if the stock stabilizes.
  • Bear put spreads cut the premium outlay by selling a lower strike, capping both the cost and the potential gain.
  • Covered calls or cash-secured puts collect less premium now that implied volatility is down about a quarter, which shrinks the cushion against further declines.

    • Risks Worth Naming

  • Wide spreads. Paying the ask on thinly traded strikes can give up a large share of the trade's expected value before the stock moves at all.
  • Two listings, two sessions. ALC trades in Zurich and New York, so the stock can open with a gap reflecting Swiss trading.
  • Lower IV isn't a forecast. Implied volatility near 31% prices a calmer stretch, but a competitor launch, an analyst call or a market-wide shock can lift it again.

    • Our implied volatility explainer covers why IV usually falls after earnings, and the OCC options disclosure document explains the risks of standardized options.

    Sources

  • Alcon: Third-quarter 2026 results press release
  • Reuters (via Euronext): Alcon shares fall as tighter eye-care market outlook raises growth concerns
  • Seeking Alpha: Alcon non-GAAP EPS of $0.91 beats, revenue misses
  • Yahoo Finance: ALC quote
  • Cboe: ALC delayed quotes

    • *By the OptionsPilot Editorial Team. Published November 11, 2026, 8:20 AM PT. This article is for education only and is not investment advice. Options involve risk and are not suitable for all investors.*